Start for free
Start for free
VP

Vestal Point Capital

Description

Vestal Point Capital is a investment firm.

Investor Profile

Vestal Point Capital has made 7 investments, with 4 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (86%)
  • Canada (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Genetics
  • Medical
  • Wellness
  • Biopharma
  • Diabetes
  • Life Science
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Vestal Point Capital frequently co-invest with?

CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners
North America, California, United States, Palo Alto
Co-Investments: 5
Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Bain Capital Life Sciences
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 3
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Deep Track Capital
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 2
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 4
Logos Capital
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 2
Janus Henderson Investors
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 4
Invus
Invus
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by Vestal Point Capital?

Solid Biosciences

Marlborough, Massachusetts, United States

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

BiotechnologyGeneticsHealth CareMedical
Post Ipo EquityFeb 18, 2025
Amount Raised: $200,000,000
enGene

Vancouver, British Columbia, Canada

enGene is a biotechnology company develops treatment for mucosal diseases through inducing therapeutic proteins of harmful proteins.

BiotechnologyDiabetesGeneticsHealth Care
Post Ipo EquityOct 25, 2024
Amount Raised: $43,188,771
OnKure Therapeutics

Boulder, Colorado, United States

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

BiotechnologyLife SciencePrecision MedicineTherapeutics
Post Ipo EquityOct 4, 2024
Amount Raised: $65,000,000
Tenax Therapeutics

Chapel Hill, North Carolina, United States

Tenax Therapeutics focuses on identifying and developing treatments that address cardiovascular and pulmonary diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityAug 6, 2024
Amount Raised: $100,000,000
Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Post Ipo EquityFeb 27, 2024
Amount Raised: $100,000,000
Dianthus Therapeutics

Waltham, Massachusetts, United States

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityJan 22, 2024
Amount Raised: $230,000,000
Solid Biosciences

Marlborough, Massachusetts, United States

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

BiotechnologyGeneticsHealth CareMedical
Post Ipo EquityJan 8, 2024
Amount Raised: $109,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator